(Q41324755)

29 September 2017

1 reference

title

Antimicrobial therapy for intraabdominal infection (English)

1 reference

29 September 2017

Nathens AB

1

1 reference

29 September 2017

Rotstein OD

series ordinal

2

1 reference

29 September 2017

language of work or name

English

0 references

publication date

1 December 1996

1 reference

The American Journal of Surgery

29 September 2017

published in

1 reference

29 September 2017

volume

172

1 reference

29 September 2017

issue

6A

1 reference

29 September 2017

page(s)

1S-6S

1 reference

A review. Lessons from an animal model of intra-abdominal sepsis

29 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2896%2900343-1

Evaluation of new anti-infective drugs for the treatment of intraabdominal infections. Infectious Diseases Society of America and the Food and Drug Administration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2896%2900343-1

Antibiotic treatment for surgical peritonitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2896%2900343-1

Results of a multicenter trial comparing imipenem/cilastatin to tobramycin/clindamycin for intra-abdominal infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2896%2900343-1

Results of a randomized trial comparing sequential intravenous/oral treatment with ciprofloxacin plus metronidazole to imipenem/cilastatin for intra-abdominal infections. The Intra-Abdominal Infection Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2896%2900343-1

Guidelines for clinical care: anti-infective agents for intra-abdominal infection. A Surgical Infection Society policy statement

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2896%2900343-1

Studies of risk factors for aminoglycoside nephrotoxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2896%2900343-1

Effect of altered volume of distribution on aminoglycoside levels in patients in surgical intensive care

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2896%2900343-1

A multicentric study of netilmicin once daily versus thrice daily in patients with appendicitis and other intra-abdominal infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2896%2900343-1

Intravenous administration of gentamicin once daily versus thrice daily in adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2896%2900343-1

Once versus thrice daily gentamicin in patients with serious infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2896%2900343-1

Clostridium difficile diarrhea and colonization after treatment with abdominal infection regimens containing clindamycin or metronidazole

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2896%2900343-1

Efficacy of a beta-lactamase inhibitor combination for serious intraabdominal infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2896%2900343-1

Meropenem versus tobramycin plus clindamycin for treatment of intraabdominal infections: results of a prospective, randomized, double-blind clinical trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2896%2900343-1

Management of intra-abdominal infections. The case for intraoperative cultures and comprehensive broad-spectrum antibiotic coverage. The Canadian Intra-abdominal Infection Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2896%2900343-1

Enterococcal bacteremia in surgical patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2896%2900343-1

Definition of the role of enterococcus in intraabdominal infection: analysis of a prospective randomized trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2896%2900343-1

Enteric absorption of ciprofloxacin during the immediate postoperative period

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2896%2900343-1

Reliability of criteria for predicting persistent or recurrent sepsis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2896%2900343-1

Perforated or gangrenous appendicitis treated with aminoglycosides. How do bacterial cultures influence management?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2896%2900343-1

10.1016/S0002-9610(96)00343-1

7 January 2021

Identifiers

DOI

1 reference

29 September 2017

1 reference